Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma uk limited - granisetron hydrochloride - film-coated tablet - 1 milligram(s) - serotonin (5ht3) antagonists; granisetron

Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma uk limited - granisetron hydrochloride - film-coated tablet - 2 milligram(s) - serotonin (5ht3) antagonists; granisetron

Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - granisetron hydrochloride - film-coated tablet - 1 milligram(s) - serotonin (5ht3) antagonists; granisetron

Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - granisetron hydrochloride - film-coated tablet - 2 milligram(s) - serotonin (5ht3) antagonists; granisetron

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - ivosidenib, quantity: 250 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; sodium lauryl sulfate; titanium dioxide; hypromellose; triacetin; indigo carmine aluminium lake; hypromellose acetate succinate; lactose monohydrate - cholangiocarcinoma,tibsovo is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an isocitrate dehydrogenase-1 (idh1) r132 mutation after at least one prior line of systemic therapy.,acute myeloid leukaemia,tibsovo is indicated for the treatment of acute myeloid leukaemia (aml) that carries an idh1 r132 mutation:,? as monotherapy, or in combination with azacitidine, in newly diagnosed patients who are not eligible to receive intensive induction chemotherapy; or,? as monotherapy in patients whose aml is relapsed and/or refractory to prior therapy.

Malta - English - Medicines Authority

sigillata limited - granisetron hydrochloride - film-coated tablet - granisetron hydrochloride 1.12 milligram(s) - antiemetics and antinauseants

Malta - English - Medicines Authority

sigillata limited - granisetron hydrochloride - film-coated tablet - granisetron hydrochloride 2.24 milligram(s) - antiemetics and antinauseants

Malta - English - Medicines Authority

sigillata limited (ireland) inniscarra, main street, rathcoole, co. dublin d24 e029 , ireland - granisetron hydrochloride - film-coated tablet - granisetron hydrochloride 1 mg - antiemetics and antinauseants

Malta - English - Medicines Authority

sigillata limited (ireland) inniscarra, main street, rathcoole, co. dublin d24 e029 , ireland - granisetron hydrochloride - film-coated tablet - granisetron hydrochloride 2 mg - antiemetics and antinauseants

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - riociguat, quantity: 1 mg - tablet, film coated - excipient ingredients: hypromellose; crospovidone; lactose monohydrate; hyprolose; sodium lauryl sulfate; microcrystalline cellulose; magnesium stearate; propylene glycol; titanium dioxide; iron oxide yellow - pulmonary arterial hypertension:,adempas, as monotherapy or in combination with approved pah treatments (endothelin receptor antagonists or inhaled or subcutaneous prostanoids), is indicated for the treatment of:,? idiopathic pulmonary arterial hypertension,? heritable pulmonary arterial hypertension,? pulmonary arterial hypertension associated with connective tissue diseases or,? pulmonary arterial hypertension associated with congenital heart disease in adult patients with who functional class ii, lll or iv symptoms,chronic thromboembolic pulmonary hypertension:,adempas is indicated for the treatment of:,persistent or recurrent chronic thromboembolic pulmonary hypertension (cteph) after surgical treatment or,inoperable cteph in adult patients with who functional class ii, lll or iv symptoms